Key facts
- VitVio’s last known valuation is $38.0M (Oct 2025).
- It has raised $10.0M across 1 recorded rounds; the latest was Seed Round ($2.0M) in Mar 2024.
- Notable investors include Tiny Supercomputer Investment Company, Tampa Bay Wave, ABHI US Accelerator, Balnord, Bek Ventures — 12 tracked in total.
- VitVio has filed 1 Form D with the SEC, most recently Mar 2024 ($2.0M sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for VitVio
Funding rounds
1 roundsAbout VitVio
Developer of an artificial intelligence-driven computer vision platform designed to enhance the efficiency and safety of hospital operating theaters. The company platform automatically tracks and analyses surgical procedures, equipment and tool tracking, and adherence to protocols in real-time increasing the number of surgeries performed per day, reducing delays, improving communication actionability, and reducing the likelihood of readmissions, enabling hospitals to perform more surgeries within a day to shorten waitlists and improve profitability, decrease infection and readmission rates, and reduce waste in surgical tools.
- Sector
- Healthcare
- HQ
- Wilmington, DE, United States
- Founded
- 2023
- Employees
- 32
- Website
- vitvio.com/
- Ownership
- Privately Held (backing)
VitVio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VitVio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VitVio in its N-PORT filings yet. We sweep new filings monthly.